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Abstract Reconstructions of large segmental bone defects
after resection of bone tumours with massive structural
allografts have a high number of reported complications
including fracture, infection and non-union. Our goal is to
report the survival and complications of massive allografts
in our patients. A total of 32 patients were evaluated for
fracture, infection, non-union rate and survival of their
massive allograft reconstructions. The average follow-up
for this group was five years and three months. The total
fracture rate was 13% with a total infection rate of 16%. We
found a low union rate of 25%. The total survival of the
allografts was 80.8% (± 18.7%) after five years. We found a
five-year allograft survival of 80.8% which is comparable
with other studies.
Résumé La reconstruction des larges pertes de substances
osseuses après la résection des tumeurs osseuses par des
allogreffes structurales est pourvoyeuse d’un pourcentage
élevé de complications, telles que fractures, infections et
pseudarthroses. Le but de notre étude est de rapporter la
courbe de survie et les complications de ces allogreffes
massives. 32 patients ont été évalués en terme de fractures,
d’infections et de pseudarthroses, après mise en place
d’allogreffes massives, le suivi moyen du groupe a été de 5
ans et 3 mois. le taux de fractures est de 13%, le taux
d’infections de 16%. Nous avons trouvé un taux relative-
ment bas de consolidation 25%. La survie de ces
allogreffes, globalement est de 80,8% (± 18,7%) après 5
ans. le taux de survie de ces allogreffes à plus de 5 ans est
de 80,8%, il est comparable aux autres études.
Introduction
Limb-saving surgery of bone tumours has increased due to
improvement in imaging, adjuvant chemotherapy and
radiotherapy. Bone tumour resections result in large
segmental bone defects. Large massive cortical allografts,
large endoprostheses or a combination of both (composite)
are the state of the art for reconstruction. Allograft fixation
can be achieved with internal fixation devices (plate,
intramedullary nail) as an intercalary graft or with the stem
of an endoprosthesis (composite) [3, 4, 8]. However, the
use of massive allografts has a high number of reported
complications such as like fracture, infection and non-union
[2–4]. The purpose of this study was to analyse the number
of complications (fracture, infection, non-union) and sur-
vival of massive allograft reconstructions in our patients.
Patients and methods
Our investigation encompasses 32 patients who had a
cylindrical segmental allograft reconstruction of the femur,
tibia or humerus. All 32 reconstructions were performed
between April 1992 and May 2005 at our department. The
mean age of the 18 female and 14 male patients was
27 years (range: 6–78 years) at the time of operation.
The diagnoses included 14 osteosarcomas, five Ewing’s
sarcomas, five chondrosarcomas, two adamantinomas, three
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and one haemangioendothelioma. The minimum follow-up
was one year, except in cases of death or allograft failure.
The average follow-up was five years and three months
(range: 1 month–14 years and 4 months). No patients were
lost to follow-up.
In 18 cases the lesion was close to the joint and the
defect was reconstructed with an allograft-prosthesis (Wal-
demar Link, Hamburg, Germany) composite and included
eight knee, six hip and four shoulder prostheses. In these
patients the graft was fixed by means of the stem of the
endoprosthesis (Fig. 1). An allograft in combination with an
arthrodesis nail (Waldemar Link, Hamburg, Germany) was
used in three patients after resection of the knee joint
including the extensor apparatus. In 11 cases with adequate
margins in relation to the joints, fixation of an intercalary
allograft was performed with an intramedullary nail and/or
plate (Synthes, Philadelphia, PA, USA).
Of the total group 15 defects were reconstructed in the
femur, 11 in the tibia and six in the humerus, with a total of
43 host-donor junctions. Of these, 11 were metaphyseal and
32 were diaphyseal junctions.
The surgical procedure consisted of resection of the
lesion with appropriate bone and soft tissue margins. All
grafts were fresh deep-frozen. The allograft was thawed in a
warm saline solution, cut to proper length, sized to fit the
bone defect and inserted. All allograft-host junctions were
made with a transverse osteotomy. Antibiotics (Cefacidal 3
times 1 g) were given intravenously according to a standard
prophylactic protocol.
Progressive passive range of motion exercises started
one week after surgery, followed by partial weight-bearing
until 12 weeks postoperatively. After three months full
weight-bearing was allowed. Most patients were seen post-
operatively at three months, six months, one year, two years,
five years and then every three years. Plain radiographs were
taken at every visit and the functional score of the Musculo-
skeletal Tumour Society (MTST) was recorded.
The clinical records and all the follow-up radiographs
were reviewed for each patient. Union of the allograft-host
junction was considered to have occured if the junction line
was no longer visible or the junction was bridged by
periosteal bone on the anteroposterior and lateral radio-
graphs. The allograft survival rate was estimated using the
Kaplan-Meier test. Fracture/failure of the reconstruction or
allograft removal either as a revision procedure or ampu-
tation was considered as an endpoint of survival.
Results
A fracture occurred in four patients (13%). Two patients
had a reconstruction with plate fixation and two a
reconstruction with an arthrodesis nail. In five patients an
infection was observed (16%). Infection occurred in two
patients with internal fixation, one with an arthrodesis nail
and in two patients with an endoprosthesis. Non-union was
observed in four patients with internal fixation and in 12
patients with an endoprosthesis leading to a union rate of
25%. Overall survival of the 32 allograft reconstructions
was 93.5±8.6% at one year and 80.8±18.7% at five years
(Fig. 2). The average postoperative MTST functional score
of the group was 21.8 points (max. 30) or 72.7% at the last
follow-up.
Complications
Of the 32 patients, four patients died of pulmonary
metastases during follow-up. In these patients the last
examination was taken as follow-up.
Twenty-five patients were continuously disease free, and
three patients had no evidence of disease after resection of a
local recurrence.
Three patients had an amputation. In one patient with an
endoprosthesis an amputation was carried out after
Fig. 1 Fixation of the allograft
with the stem of the endopros-
thesis, non-union 24 months
postoperatively
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Fig. 2 Survival curve of the massive allograft reconstructions
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found. One patient had an amputation after five months due
to a deep infection of the intercalary graft. The third patient
had an amputation of graft and endoprosthesis after
87 months for local recurrence.
One patient had an intercalary allograft removed due to a
deep infection (at 159 months). After débridement and
removal of the graft a mega-prosthesis was implanted. Two
patients with an endoprosthesis had a deep infection leading
to a chronic fistula which was not treated. In the intercalary
graft group two plate fractures were observed leading to a
stable fibrous non-union in one and a revision in the other
(Fig. 3). All three patients with an arthrodesis nail suffered
from complications. One had a deep infection which was
débrided and treated with local antibiotics and two
developed a fracture of the arthrodesis nail which was
treated with a revision of the nail.
Discussion
The high fracture rate of up to 38% after allograft
reconstructions reported in several studies was related to
irradiation, stress concentration near the end of a fixation
device and screw holes used for plate fixation [10, 13, 14,
18]. The fracture risk of plate fixation is supported by our
study, as two of the four fractures that occurred were after
plate fixation. The fracture rate of 13% was low in our
study group probably due to a high number of patients
treated with an endoprosthesis with a long solid stem.
Reconstructions with an arthrodesis nail are associated
with a high rate of complications and a reported survival of
54% after five years [9]. Donati et al. [5]r e p o r t e d
reoperations after arthrodesis nail reconstructions in more
than 50% in their study. Although we only used the
arthrodesis nail in three patients complications occurred in
all (two fractures and one infection). Failure is most likely
caused by high concentrations of stress at the site of the
former knee joint and ends of the fixation. It seems that the
arthrodesis nail should be used only in cases where no
alternatives are available.
Our infection rate was 16%. These rates are comparable
with other studies that reported rates varying from 8 to 19%
[3, 4, 12].
Non-union was seen in 68% of the total group. Non-
union was related to fixation with an endoprosthesis in
75%. This relatively high number of non-unions is probably
caused by stress shielding of the large stems that leave the
osteotomy site relatively unloaded. Despite non-union an
endoprosthesis in combination with an allograft appeared to
be stable since no failures of reconstruction were observed
in this group. Non-union was seen in 44% of the patients
with an intercalary graft with internal fixation. Non-union
in combination with a plate fixation led to failure of fixation
in 50%. Non-union seems to be a risk factor for failure in
the group with a plate fixation device. The union rate is
reported to be influenced by stability of fixation and degree
of contact between host and graft. Other factors decreasing
union rates are chemotherapy and radiation [9, 10, 13, 14].
Metaphyseal junctions have a lower non-union rate as
compared to the cortical diaphyseal junctions [3, 4, 6]. This
difference will also influence the non-union rate of the
endoprosthetic reconstructions in which the grafts have
predominantly diaphyseal junctions.
Deijkers et al. [3, 4] reported a functional MSTS score of
77% after segmental reconstructions. Lietman et al. [10]
reported a range of 58–92% MSTS score. The average
functional score of 73% in our study is comparable with
these reports.
The five-year survival of 81% of all the allograft
reconstructions in our study is consistent with others [11,
20]. Mankin et al. [11] reported an allograft survival of
76%. In this last study a subgroup with intercalary grafts
had a survival of 84% compared to 73% of osteoarticular
grafts and 77% for allograft-endoprosthesis reconstructions.
Musculo et al. [13, 14] reported an intercalary graft survival
of 79% after five years. Enneking and Campanacci [6]
reported only partial incorporation of the allograft in a
retrieval study and union occurred slowly with an average
of 12 months. These findings indicate that the allograft only
partially supports the overall strength of the entire recon-
struction. Since intramedullary nails and plates are only
intended as a temporary fixation, we anticipated a higher
failure rate in this group as in the study of Wedin and Bauer
[19] who reported a lower failure rate in endoprosthetic
reconstructions of metastatic lesions in the proximal femur
compared to reconstruction nails. However, we found no
difference in survival between massive allograft fixation
with an endoprosthesis or internal fixation device. Cement
Fig. 3 Non-union and failure of
fixation in an intercalary allo-
graft reconstruction
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strength of the reconstruction [7]. Cement, however, will
be more demanding to manage in revision procedures and
may obstruct a biological fixation.
A study of Zehr et al. [21] showed fewer dislocations of
a composite reconstruction compared to a reconstruction
with only a mega-prosthesis. An endoprosthesis in combi-
nation with an allograft has the advantage of load sharing.
Furthermore, tendons can be reattached to soft tissue left on
the graft. A composite reconstruction is more often
complicated by infections. The survival of the composite
was better than the mega-prosthesis although the difference
was not significant.
Reconstructions with an endoprosthesis lead to a
predictable outcome. Endoprosthetic reconstructions, how-
ever, are associated with complications such as loosening
and dislocation of the implant [15, 17] causing the survival
of an endoprosthesis to deteriorate in time.
Reconstructions with intercalary grafts are less predict-
able due to a higher complication rate in the first
three years. After three years the survival of intercalary
grafts remains stable [1]. A further advantage of intercalary
grafts is the preservation of the opposite growth plate in the
young [2, 16]. Each method of fixation has its own
advantages, indications and limitations.
The numbers in this study are too small to draw firm
conclusions. The comparison with other studies is difficult
because every reconstruction is different in diagnosis, local-
isation, fixation, adjuvant therapy, soft tissue envelope and
size of the defect. Host-graft contact and size fitting of the
graft are other important factors influencing results [3, 4, 13,
14]. The study has a limited follow-up although sufficient as
failure predominantly occurs in the first three years [3, 4].
Conclusions
We found a five-year survival of massive allograft recon-
structions of 80.8%, which is comparable with other studies.
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